The Latest Breaking News from CCJ

Vertex Pharmaceuicals flashed a buy signal last week on positive gene-editing news. It's one of several resilient stocks to watch in the bear market.

'I’ve constantly been afraid that another fine will come through the door every time I hear the letterbox go'

  Cameco (NYSE:CCJ) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Cameco beat estimated earnings by 250.0%, reporting an EPS of $0.03 versus an estimate of $-0.02.

Customers say judgments against firms lead nowhere and compound their misery

Cameco (NYSE:CCJ) has outperformed the market over the past 20 years by 2.45% on an annualized basis producing an average annual return of 9.86%. Currently, Cameco has a market capitalization of $12.50 billion.

Uranium prices have hit their highest level since the Fukushima disaster in Japan of 2011, owing to the sanctions on uranium imports from Russia. Multi-year-high uranium prices have helped uranium stocks Cameco (CCJ), NexGen (NXE), and Denison Mines (DNN) to soar in price of late. But we think these stocks…

Retired magistrate Clive Sowerby, 78, refused to pay hundreds of pounds in fines to a private parking firm during a legal dispute which began in October 2019 and ended in a David vs Goliath showdown

Cameco (NYSE:CCJ) has outperformed the market over the past 20 years by 2.22% on an annualized basis producing an average annual return of 9.42%. Currently, Cameco has a market capitalization of $11.54 billion.

Shares of Cameco Corp (NYSE: CCJ) Thursday jumped more than 9% to close at $27.12 on rising uranium prices amid the Russia-Ukraine tensions.